Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Filed with BSE · ISIN INE194R01017 · · 15 pages · English
Summary by 6ix AI
The call highlighted significant growth in total income, EBITDA, and net profit compared to the previous year, indicating strong performance across various business segments. Management expressed confidence in exceeding previous revenue targets and discussed ongoing improvements in financial controls and operational efficiencies. The transcript also includes a question-and-answer session where management addressed inquiries about growth drivers and future projections for the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Fredun Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Fredun Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Approved The Proposal For Making An Application To National Stock Exchange Of India Limited (NSE) For Listing And Trading Of The Equity Shares Of The Company On NSE.
Follow Fredun Pharmaceuticals into a list and get an email when it puts out news.
Follow Fredun Pharmaceuticals